Skip to main content

Written question asked by Baroness Pidgeon (Liberal Democrat) on Wednesday, 15 July 2026, in the House of Lords. It was due for an answer on Wednesday, 29 July 2026. It was answered by Baroness Merron (Labour) on Friday, 28 August 2026 on behalf of the Department of Health and Social Care.


Pancreatic Cancer: Genomics

Question

To ask His Majesty's Government what steps they are taking to educate and equip healthcare professionals to engage in genomic testing for patients with pancreatic cancer.

Answer

The NHS England Genomics Education Programme provides education and training to support healthcare professionals in the use of genomic medicine. Working with the NHS Genomic Medicine Service, it delivers a national education programme designed to build genomic knowledge and skills across the healthcare workforce.

As part of this offer, the programme has developed GeNotes, a multi-professional clinical resource that supports clinicians to identify when genomic testing is appropriate, order the correct test, interpret results, and communicate them to patients. GeNotes aligns with the National Genomic Test Directory and provides both point-of-care guidance and more in-depth learning opportunities.

The resource includes educational material relevant to pancreatic cancer, including guidance to support clinicians managing patients with pancreatic cancer who may benefit from genomic testing and the interpretation of genomic results.

NHS England continues to work with healthcare professionals, academics, and professional organisations to ensure genomic education and training resources remain up to date and support the appropriate use of genomics across healthcare services.


Secondary information

Type
Written question
Reference
HL2160
Session
2026-27
Subjects
Health services Training Genomics Pancreatic cancer
Link
View this Written question on www.parliament.uk